News
-
-
PRESS RELEASE
Northern Data Group Publishes Consolidated Financial Statements for the Year Ended December 31, 2022
Northern Data Group releases consolidated financial statements for the year ended December 31, 2022, confirming financial targets for 2023 and 2024. Find detailed information on the company's website -
PRESS RELEASE
Bike24 Holding AG: Strong double-digit growth rates in localized markets and full-bike segment but ongoing weak consumer sentiment in core markets during FY 2023
BIKE24 Holding AG reported strong double-digit growth rates in localized markets and the full-bike segment despite weak consumer sentiment in core markets during FY 2023. The company expects sales growth of 1-5% and an adj. EBITDA margin of 0.7-4.2% for 2024 -
PRESS RELEASE
EQS-Adhoc: Dexus Finance Pty Limited: Correction: Appendix 3G - Notification regarding unquoted securities and Appendix 3H – notification of cessation of securities
Dexus Finance Pty Limited corrects inaccuracies in Appendix 3G and 3H notifications regarding Performance Rights vesting and cessation -
PRESS RELEASE
Evolva Holding in liquidation SA publishes liquidation interim financial statements and agenda for 2024 annual general meeting; reports positive purchase price adjustment of CHF 1,929,000 under SPA; g
Evolva Holding SA in liquidation publishes liquidation interim financial statements and agenda for 2024 annual general meeting; reports a positive purchase price adjustment of CHF 1,929,000 under SPA -
PRESS RELEASE
Biophytis a présenté son protocole de phase 3 dans le traitement de la sarcopénie
Biophytis a présenté son protocole de phase 3 dans le traitement de la sarcopénie lors de l’ICFSR. L'étude SARA-31 vise à évaluer l'efficacité de RuvembriTM. La société recherche des partenaires pharmaceutiques pour le développer -
-
PRESS RELEASE
Relief Therapeutics Enters into Exclusive U.S. License and Supply Agreement with Eton Pharmaceuticals for PKU GOLIKE
Relief Therapeutics enters into exclusive U.S. license and supply agreement with Eton Pharmaceuticals for PKU GOLIKE. Partnership aims to increase awareness and adoption of PKU medical formula -
-
